Figure 1. The level of total PDGF receptor α protein (nonphospho or phospho) from either untreated or PDGF-treated MG63 cells remained similar, detected by either PathScan® Total PDGF Receptor α Sandwich ELISA Kit #7318 or Western analysis. The absorbance readings at 450 nm are shown in the top figure, while the corresponding Western blot using PDGF Receptor α Rabbit mAb #3174 (left panel ) or Phospho-PDGF Receptor α (Tyr754) (23B2) Rabbit mAb #2992 (right panel) is shown in the bottom figure.
Figure 2: The relationship between protein concentration of untreated or PDGF-treated MG63 cell lysates and the absorbance at 450 nm is shown. Cells (85% confluence) were serum starved overnight and then treated with PDGF (50 ng/ml) for 7 min. at 37°C.
Figure 3. Kit specificity as demonstrated by Western analysis of the ELISA microwell captured protein. Lysates were prepared from MG63 cells and incubated in microwells coated with the PDGF Receptor α capture antibody. Wells were washed, and the captured protein was solubilized in SDS gel loading buffer. Western analysis of MG63 cell starting lysate (lanes 1 & 2) and the captured protein (lanes 3 & 4) was performed using PDGF Receptor α (D1E1E) Rabbit mAb #3174. The major bands detected in the captured material corresponds to the PDGF Receptor α protein (lanes 3 & 4).
|7318C||1 Kit (96 assays)||$ 499|
Our US office is closed in observance of Thanksgiving. We will reopen on Friday, November 27th.
Thank you for your patience.
|Product Includes||Volume||Solution Color|
|PDGF Receptor α Rabbit mAb Coated Microwells||96 tests|
|Biotinylated PDGF Receptor-α Rabbit Detection mAb||1 ea||Green (Lyophilized)|
|HRP-Linked Streptavidin (ELISA Formulated)||1 ea||Red (Lyophilized)|
|Detection Antibody Diluent||11 ml||Green|
|HRP Diluent||11 ml||Red|
|TMB Substrate 7004||11 ml|
|STOP Solution 7002||11 ml|
|Sealing Tape||2 ea|
|ELISA Wash Buffer (20X) 9801||25 ml|
|ELISA Sample Diluent||25 ml||Blue|
|Cell Lysis Buffer (10X) 9803||15 ml|
CST's PathScan® Total PDGF Receptor α Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects endogenous levels of total PDGF receptor α protein. A PDGF receptor α Rabbit Antibody has been coated onto the microwells. After incubation with cell lysates, both phospho and nonphospho PDGF receptor α proteins are captured by the coated antibody. Following extensive washing, Biotinylated PDGF Receptor α Rabbit mAb is added to detect both the captured phospho and nonphospho PDGF receptor α protein. HRP-linked Streptavidin is then used to recognize the bound detection antibody. HRP substrate, TMB, is added to develop color. The magnitude of optical density for this developed color is proportional to the quantity of total PDGF receptor α protein.
Antibodies in kit are custom formulations specific to kit.
NOTE: Prepare solutions with purified water.
*NOTE: Some PathScan® ELISA Kits may include HRP-Linked Streptavidin in place of HRP-Linked Antibody.
NOTE: Initial color of positive reaction is blue, which changes to yellow upon addition of STOP Solution.
posted November 2013
Protocol Id: 204
CST's PathScan® Total PDGF Receptor α Sandwich ELISA Kit #7318 detects endogenous levels of total PDGF receptor α protein. As shown in Figure 1, the level of total PDGF receptor α (phospho or nonphospho) before or after treatment of stimulator, remains unchanged as shown by Western analysis or by PathScan® Total PDGF Receptor α Sandwich ELISA Kit #7318. In Figure 3, Western blot analysis of protein captured in the PDGF Receptor α Mouse mAb coated microwell shows major bands corresponding to the PDGF receptor α protein. This kit detects proteins from the indicated species, as determined through in-house testing, but may also detect homologous proteins from other species.
Platelet derived growth factor (PDGF) family proteins exist as several disulphide-bonded, dimeric isoforms (PDGF AA, PDGF AB, PDGF BB, PDGF CC, and PDGF DD) that bind in a specific pattern to two closely related receptor tyrosine kinases, PDGF receptor α (PDGFRα) and PDGF receptor β (PDGFRβ). PDGFRα and PDGFRβ share 75% to 85% sequence homology between their two intracellular kinase domains, while the kinase insert and carboxy-terminal tail regions display a lower level (27% to 28%) of homology (1). PDGFRα homodimers bind all PDGF isoforms except those containing PDGF D. PDGFRβ homodimers bind PDGF BB and DD isoforms, as well as the PDGF AB heterodimer. The heteromeric PDGF receptor α/β binds PDGF B, C, and D homodimers, as well as the PDGF AB heterodimer (2). PDGFRα and PDGFRβ can each form heterodimers with EGFR, which is also activated by PDGF (3). Various cells differ in the total number of receptors present and in the receptor subunit composition, which may account for responsive differences among cell types to PDGF binding (4). Ligand binding induces receptor dimerization and autophosphorylation, followed by binding and activation of cytoplasmic SH2 domain-containing signal transduction molecules, such as GRB2, Src, GAP, PI3 kinase, PLCγ, and NCK. A number of different signaling pathways are initiated by activated PDGF receptors and lead to control of cell growth, actin reorganization, migration, and differentiation (5). Tyr751 in the kinase-insert region of PDGFRβ is the docking site for PI3 kinase (6). Phosphorylated pentapeptides derived from Tyr751 of PDGFRβ (pTyr751-Val-Pro-Met-Leu) inhibit the association of the carboxy-terminal SH2 domain of the p85 subunit of PI3 kinase with PDGFRβ (7). Tyr740 is also required for PDGFRβ-mediated PI3 kinase activation (8).
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.